147 related articles for article (PubMed ID: 31958129)
1. Impact of BMI for clinical outcomes in Japanese breast cancer patients.
Gondo N; Sawaki M; Hattori M; Yoshimura A; Kotani H; Adachi Y; Kataoka A; Sugino K; Mori M; Horisawa N; Terada M; Ozaki Y; Iwata H
Jpn J Clin Oncol; 2020 Mar; 50(3):230-240. PubMed ID: 31958129
[TBL] [Abstract][Full Text] [Related]
2. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
3. Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer.
Chung IY; Lee JW; Lee JS; Park YR; Min YH; Lee Y; Yoon TI; Sohn G; Lee SB; Kim J; Kim HJ; Ko BS; Son BH; Ahn SH
PLoS One; 2017; 12(3):e0170311. PubMed ID: 28248981
[TBL] [Abstract][Full Text] [Related]
4. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
[TBL] [Abstract][Full Text] [Related]
5. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project.
Kwan ML; Chen WY; Kroenke CH; Weltzien EK; Beasley JM; Nechuta SJ; Poole EM; Lu W; Holmes MD; Quesenberry CP; Pierce JP; Shu XO; Caan BJ
Breast Cancer Res Treat; 2012 Apr; 132(2):729-39. PubMed ID: 22187127
[TBL] [Abstract][Full Text] [Related]
6. Does obesity have an effect on outcomes in triple-negative breast cancer?
Mowad R; Chu QD; Li BD; Burton GV; Ampil FL; Kim RH
J Surg Res; 2013 Sep; 184(1):253-9. PubMed ID: 23768767
[TBL] [Abstract][Full Text] [Related]
7. Underweight and breast cancer recurrence and death: a report from the Korean Breast Cancer Society.
Moon HG; Han W; Noh DY
J Clin Oncol; 2009 Dec; 27(35):5899-905. PubMed ID: 19805676
[TBL] [Abstract][Full Text] [Related]
8. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
[TBL] [Abstract][Full Text] [Related]
9. Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis.
Sun L; Zhu Y; Qian Q; Tang L
Medicine (Baltimore); 2018 Jun; 97(26):e11220. PubMed ID: 29952978
[TBL] [Abstract][Full Text] [Related]
10. Extremes in body mass index affect overall survival in women with cervical cancer.
Clark LH; Jackson AL; Soo AE; Orrey DC; Gehrig PA; Kim KH
Gynecol Oncol; 2016 Jun; 141(3):497-500. PubMed ID: 27058838
[TBL] [Abstract][Full Text] [Related]
11. Impact of African ancestry on the relationship between body mass index and survival in an early-stage breast cancer trial (ECOG-ACRIN E5103).
Ballinger TJ; Jiang G; Shen F; Miller KD; Sledge GW; Schneider BP
Cancer; 2022 Jun; 128(11):2174-2181. PubMed ID: 35285940
[TBL] [Abstract][Full Text] [Related]
12. Body mass index and survival after diagnosis of invasive breast cancer: a study based on the Japanese National Clinical Database-Breast Cancer Registry.
Kawai M; Tomotaki A; Miyata H; Iwamoto T; Niikura N; Anan K; Hayashi N; Aogi K; Ishida T; Masuoka H; Iijima K; Masuda S; Tsugawa K; Kinoshita T; Nakamura S; Tokuda Y
Cancer Med; 2016 Jun; 5(6):1328-40. PubMed ID: 26923549
[TBL] [Abstract][Full Text] [Related]
13. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
J BUON; 2013; 18(2):335-41. PubMed ID: 23818343
[TBL] [Abstract][Full Text] [Related]
14. Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival.
Jeon YW; Kang SH; Park MH; Lim W; Cho SH; Suh YJ
BMC Cancer; 2015 Nov; 15():865. PubMed ID: 26546331
[TBL] [Abstract][Full Text] [Related]
15. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.
Dignam JJ; Wieand K; Johnson KA; Fisher B; Xu L; Mamounas EP
J Natl Cancer Inst; 2003 Oct; 95(19):1467-76. PubMed ID: 14519753
[TBL] [Abstract][Full Text] [Related]
16. Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer.
Scholz C; Andergassen U; Hepp P; Schindlbeck C; Friedl TW; Harbeck N; Kiechle M; Sommer H; Hauner H; Friese K; Rack B; Janni W
Breast Cancer Res Treat; 2015 Jun; 151(3):569-76. PubMed ID: 25962694
[TBL] [Abstract][Full Text] [Related]
17. Body mass index and absolute lymphocyte count predict disease-free survival in Korean breast cancer patients.
Ko SM; Lee J; Bae SJ; Baik SJ; Ji J; Kim D; Ahn SG; Jeong J
Br J Cancer; 2021 Jul; 125(1):119-125. PubMed ID: 33875823
[TBL] [Abstract][Full Text] [Related]
18. Impact of body mass index on clinical outcomes in triple-negative breast cancer.
Ademuyiwa FO; Groman A; O'Connor T; Ambrosone C; Watroba N; Edge SB
Cancer; 2011 Sep; 117(18):4132-40. PubMed ID: 21387276
[TBL] [Abstract][Full Text] [Related]
19. Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer.
Martel S; Poletto E; Ferreira AR; Lambertini M; Sottotetti F; Bertolini I; Montemurro F; Bernardo A; Risi E; Zanardi E; Ziliani S; Mura S; Dellepiane C; Del Mastro L; Minisini AM; Puglisi F
Breast; 2018 Feb; 37():142-147. PubMed ID: 29161652
[TBL] [Abstract][Full Text] [Related]
20. Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial.
Martel S; Lambertini M; Agbor-Tarh D; Ponde NF; Gombos A; Paterson V; Hilbers F; Korde L; Manukyants A; Dueck A; Maurer C; Piccart M; Moreno-Aspitia A; Desmedt C; Di Cosimo S; de Azambuja E
J Natl Compr Canc Netw; 2021 Jan; 19(2):181-189. PubMed ID: 33401235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]